1 Product identity
Ingredient risk
Contains restricted ingredients
Ferrex 150
BrandBreckenridge Pharmaceutical→Mineral Capsule 14 ingredients 1 banned 1 caution DSLD #239604Net contents: 100 Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2020-11-21
2 Ingredients (14)
IngredientGroupSafety
GelatinGelatin—
Microcrystalline CelluloseCellulose—
Stearic AcidStearic Acid—
Polyethylene GlycolPolyethylene glycol—
Citric AcidCitric Acid—
PolyvinylpyrrolidonePovidone—
FD&C Yellow #5 LakeColor—
FD&C Red #40 LakeColor—
FD&C Red #3 LakeColor—
FD&C Blue #1 LakeColor—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ Contains an ingredient banned in ≥1 country
Titanium Dioxide 🇫🇷 🇪🇺 — France banned TiO₂ in food from January 2020, first EU country.
⚠️ Use with caution — restricted in some markets
Iron — Iron supplementation in iron-replete patients may increase cardiovascular and cancer risk — always document deficiency before prescribing [1].
3 Safety cross-reference
Iron — Use with Caution
⚠ GI upset, constipation
⚠ Fatal toxicity in children
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Titanium Dioxide — Banned in ≥1 country
⚠ EFSA: can no longer be considered safe as food additive (2021)
⚠ Genotoxicity concern (nanoparticles)
4 Label claims
• Nutrient
• All Other
• Structure/Function
5 Data source
DSLD ID239604
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2020-11-21
6 More from Breckenridge Pharmaceutical
Ferrex 1507 Cite this page
Vancouver
Pkhakadze G. Ferrex 150 — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jul 29]. Available from: https://supplement.ge/products/ferrex-150-239604/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG